Genome-Wide Association Study for Endothelial Growth Factors

Circulation: Cardiovascular Genetics

Volumn 8, Issue 2, 2015, Pages 389-397

  Lieb, Wolfgang ^a,b   Chen, Ming Huei ^a,c   Larson, Martin G ^a,e   Safa, Radwan ^d   Teumer, Alexander ^g,h   Baumeister, Sebastian E ^h   Lin, Honghuang ^a,c   Smith, Holly M ^j   Koch, Manja ^b   Lorbeer, Roberto ^h   Völker, Uwe ^g,k   Nauck, Matthias ^i,k   Völzke, Henry ^h,k   Wallaschofski, Henri ^i,k   Sawyer, Douglas B ^j   Vasan, Ramachandran S ^a,f  

^a FRAMINGHAM HEART STUDY   (United States)

^b UNIVERSITY OF KIEL   (Germany)

^c Department of Neurology ^*  (United States)

^d Division of Graduate Medical Sciences   (United States)

^e University School of Medicine   (United States)

^f BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^g Interfaculty Institute for Genetics and Functional Genomics Section Study of Health in Pomerania Clinical Epidemiological Research   (Germany)

^h Institute for Community Medicine   (Germany)

ⁱ UNIVERSITY MEDICINE GREIFSWALD   (Germany)

^j VANDERBILT UNIVERSITY   (United States)

^k DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

more..

Author keywords

angiopoietin 2; endothelial growth factors; genetics; Genome Wide Association Study; hepatocyte growth factor; Tie 2 receptor

Indexed keywords

ANGIOPOIETIN 2; ANGIOPOIETIN RECEPTOR; SCATTER FACTOR; SOLUBLE RECEPTOR TIE 2; UNCLASSIFIED DRUG; C11ORF2 PROTEIN, HUMAN; HGF PROTEIN, HUMAN; VESICULAR TRANSPORT PROTEIN;

ADULT; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; FEMALE; GENE LOCUS; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TASK PERFORMANCE; BIOLOGICAL MODEL; CLINICAL TRIAL; GENETIC PREDISPOSITION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; MIDDLE AGED; MULTICENTER STUDY; NEOPLASM;

ADULT; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HEPATOCYTE GROWTH FACTOR; HUMANS; MALE; MIDDLE AGED; MODELS, GENETIC; NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR, TIE-2; VESICULAR TRANSPORT PROTEINS;

EID: 84942940724     PISSN: 1942325X     EISSN: 19423268     Source Type: Journal    
DOI: 10.1161/CIRCGENETICS.114.000597     Document Type: Article

References (50)

1. Eklund L, Olsen BR. Tie receptors and their angiopoietin ligands are context-dependent regulators of vascular remodeling. Exp Cell Res. 2006;312:630-641. doi: 10.1016/j.yexcr.2005.09.002.
2. Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science. 1997;277:55-60.
3. Shim WS, Ho IA, Wong PE. Angiopoietin: a TIE(d) balance in tumor angiogenesis. Mol Cancer Res. 2007;5:655-665. doi: 10.1158/1541-7786. MCR-07-0072.
4. You WK, McDonald DM. The hepatocyte growth factor/c-Met signaling pathway as a therapeutic target to inhibit angiogenesis. BMB Rep. 2008;41:833-839.
5. Ylä-Herttuala S, Rissanen TT, Vajanto I, Hartikainen J. Vascular endothelial growth factors: biology and current status of clinical applications in cardiovascular medicine. J Am Coll Cardiol. 2007;49:1015-1026. doi: 10.1016/j.jacc.2006.09.053.
6. Lieb W, Safa R, Benjamin EJ, Xanthakis V, Yin X, Sullivan LM, et al. Vascular endothelial growth factor, its soluble receptor, and hepatocyte growth factor: clinical and genetic correlates and association with vascular function. Eur Heart J. 2009;30:1121-1127. doi: 10.1093/eurheartj/ehp007.
7. Lieb W, Zachariah JP, Xanthakis V, Safa R, Chen MH, Sullivan LM, et al. Clinical and genetic correlates of circulating angiopoietin-2 and soluble Tie-2 in the community. Circ Cardiovasc Genet. 2010;3:300-306. doi: 10.1161/CIRCGENETICS.109.914556.
8. Splansky GL, Corey D, Yang Q, Atwood LD, Cupples LA, Benjamin EJ, et al. The Third Generation Cohort of the National Heart, Lung, and Blood Institute's Framingham Heart Study: design, recruitment, and initial examination. Am J Epidemiol. 2007;165:1328-1335. doi: 10.1093/aje/kwm021.
9. Völzke H, Alte D, Schmidt CO, Radke D, Lorbeer R, Friedrich N, et al. Cohort profile: the study of health in Pomerania. Int J Epidemiol. 2011;40:294-307. doi: 10.1093/ije/dyp394.
10. Stein JL, Medland SE, Vasquez AA, Hibar DP, Senstad RE, Winkler AM, et al; Alzheimer's Disease Neuroimaging Initiative; EPIGEN Consortium; IMAGEN Consortium; Saguenay Youth Study Group; Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium; Enhancing Neuro Imaging Genetics through Meta-Analysis Consortium. Identification of common variants associated with human hippocampal and intracranial volumes. Nat Genet. 2012;44:552-561. doi: 10.1038/ng.2250.
11. Suhre K, Wallaschofski H, Raffler J, Friedrich N, Haring R, Michael K, et al. A genome-wide association study of metabolic traits in human urine. Nat Genet. 2011;.43:565-569. doi: 10.1038/ng.837.
12. Lorbeer R, Baumeister SE, Dörr M, Nauck M, Grotevendt A, Völzke H, et al. Circulating angiopoietin-2, its soluble receptor Tie-2, and mortality in the general population. Eur J Heart Fail. 2013;15:1327-1334. doi: 10.1093/eurjhf/hft117.
13. Vasan RS, Glazer NL, Felix JF, Lieb W, Wild PS, Felix SB, et al. Genetic variants associated with cardiac structure and function: A meta-analysis and replication of genome-wide association data. JAMA. 2009;302:168-178.
14. Psaty BM, O'Donnell CJ, Gudnason V, Lunetta KL, Folsom AR, Rotter JI, et al; CHARGE Consortium. Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium: design of prospective meta-analyses of genome-wide association studies from 5 cohorts. Circ Cardiovasc Genet. 2009;2:73-80. doi: 10.1161/CIRCGENETICS.108.829747.
15. Johnson AD, Yanek LR, Chen MH, Faraday N, Larson MG, Tofler G, et al. Genome-wide meta-analyses identifies seven loci associated with platelet aggregation in response to agonists. Nat Genet. 2010;42:608-613. doi: 10.1038/ng.604.
16. Li Y, Willer CJ, Ding J, Scheet P, Abecasis GR. MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes. Genet Epidemiol. 2010;34:816-834. doi: 10.1002/gepi.20533.
17. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet. 2006;38:904-909. doi: 10.1038/ng1847.
18. Johnson AD, Handsaker RE, Pulit SL, Nizzari MM, O'Donnell CJ, de Bakker PI. SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap. Bioinformatics. 2008;24:2938-2939. doi: 10.1093/bioinformatics/btn564.
19. Chen MH, Yang Q. GWAF: an R package for genome-wide association analyses with family data. Bioinformatics. 2010;26:580-581. doi: 10.1093/bioinformatics/btp710.
20. Vistoropsky Y, Trofimov S, Malkin I, Kobyliansky E, Livshits G. Genetic and environmental determinants of hepatocyte growth factor levels and their association with obesity and blood pressure. Ann Hum Biol. 2008;35:93-103. doi: 10.1080/03014460701822003.
21. Burdon KP, Macgregor S, Bykhovskaya Y, Javadiyan S, Li X, Laurie KJ, et al. Association of polymorphisms in the hepatocyte growth factor gene promoter with keratoconus. Invest Ophthalmol Vis Sci. 2011;52:8514-8519. doi: 10.1167/iovs.11-8261.
22. Hoshino K, Satoh T, Kawaguchi Y, Kuwana M. Association of hepatocyte growth factor promoter polymorphism with severity of interstitial lung disease in Japanese patients with systemic sclerosis. Arthritis Rheum. 2011;63:2465-2472. doi: 10.1002/art.30415.
23. Campbell DB, Li C, Sutcliffe JS, Persico AM, Levitt P. Genetic evidence implicating multiple genes in the MET receptor tyrosine kinase pathway in autism spectrum disorder. Autism Res. 2008;1:159-168. doi: 10.1002/aur.27.
24. Finn RD, Bateman A, Clements J, Coggill P, Eberhardt RY, Eddy SR, et al. Pfam: the protein families database. Nucleic Acids Res. 2014;42(Database issue):D222-D230. doi: 10.1093/nar/gkt1223.
25. Patthy L, Trexler M, Váli Z, Bányai L, Váradi A. Kringles: modules specialized for protein binding. Homology of the gelatin-binding region of fibronectin with the kringle structures of proteases. FEBS Lett. 1984;171:131-136.
26. Abecasis GR, Altshuler D, Auton A, Brooks LD, Durbin RM, Gibbs RA, et al. A map of human genome variation from population-scale sequencing. Nature. 2010;467:1061-1073. doi: 10.1038/nature09534.
27. Chen J, Yu H, Sun K, Song W, Bai Y, Yang T, et al. Promoter variant of angiopoietin-2 and plasma angiopoietin-2 are associated with risk of stroke recurrence in lacunar infarct patients. Biochem Biophys Res Commun. 2010;398:212-216. doi: 10.1016/j.bbrc.2010.06.062.
28. Meyer NJ, Li M, Feng R, Bradfield J, Gallop R, Bellamy S, et al. ANGPT2 genetic variant is associated with trauma-associated acute lung injury and altered plasma angiopoietin-2 isoform ratio. Am J Respir Crit Care Med. 2011;183:1344-1353. doi: 10.1164/rccm.201005-0701OC
29. Smith NL, Chen MH, Dehghan A, Strachan DP, Basu S, Soranzo N, et al; Wellcome Trust Case Control Consortium. Novel associations of multiple genetic loci with plasma levels of factor VII, factor VIII, and von Willebrand factor: The CHARGE (Cohorts for Heart and Aging Research in Genome Epidemiology) Consortium. Circulation. 2010;121:1382-1392. doi:10.1161/CIRCULATIONAHA.109.869156.
30. Souto JC, Almasy L, Soria JM, Buil A, Stone W, Lathrop M, et al. Genome-wide linkage analysis of von Willebrand factor plasma levels: results from the GAIT project. Thromb Haemost. 2003;89:468-474. doi: 10.1267/THRO03030468.
31. Barbalic M, Dupuis J, Dehghan A, Bis JC, Hoogeveen RC, Schnabel RB, et al. Large-scale genomic studies reveal central role of ABO in sPselectin and sICAM-1 levels. Hum Mol Genet. 2010;19:1863-1872. doi: 10.1093/hmg/ddq061.
32. Paré G, Chasman DI, Kellogg M, Zee RY, Rifai N, Badola S, et al. Novel association of ABO histo-blood group antigen with soluble ICAM-1: results of a genome-wide association study of 6,578 women. PLoS Genet. 2008;4:e1000118. doi: 10.1371/journal.pgen.1000118.
33. Paterson AD, Lopes-Virella MF, Waggott D, Boright AP, Hosseini SM, Carter RE, et al; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Genomewide association identifies the ABO blood group as a major locus associated with serum levels of soluble E-selectin. Arterioscler Thromb Vasc Biol. 2009;29:1958-1967. doi: 10.1161/ATVBAHA.109.192971.
34. Melzer D, Perry JR, Hernandez D, Corsi AM, Stevens K, Rafferty I, et al. A genome-wide association study identifies protein quantitative trait loci (pQTLs). PLoS Genet. 2008;4:e1000072. doi: 10.1371/journal. pgen.1000072.
35. Wolpin BM, Kraft P, Xu M, Steplowski E, Olsson ML, Arslan AA, et al. Variant ABO blood group alleles, secretor status, and risk of pancreatic cancer: results from the pancreatic cancer cohort consortium. Cancer Epidemiol Biomarkers Prev. 2010;19:3140-3149. doi: 10.1158/1055-9965. EPI-10-0751.
36. Amundadottir L, Kraft P, Stolzenberg-Solomon RZ, Fuchs CS, Petersen GM, Arslan AA, et al. Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet. 2009;41:986-990. doi: 10.1038/ng.429.
37. Macdonald PR, Progias P, Ciani B, Patel S, Mayer U, Steinmetz MO, et al. Structure of the extracellular domain of Tie receptor tyrosine kinases and localization of the angiopoietin-binding epitope. J Biol Chem. 2006;281:28408-28414. doi: 10.1074/jbc.M605219200.
38. Kiechl S, Pare G, Barbalic M, Qi L, Dupuis J, Dehghan A, et al. Association of variation at the abo locus with circulating levels of sicam-1, sP-selectin and sE-selectin: a meta-analysis. Circ Cardiovasc Genet. 2011;4:681-686. doi: 10.1161/CIRCGENETICS.111.960682.
39. Aird I, Bentall HH, Roberts JA. A relationship between cancer of stomach and the ABO blood groups. Br Med J. 1953;1:799-801.
40. Tanikawa C, Urabe Y, Matsuo K, Kubo M, Takahashi A, Ito H, et al. A genome-wide association study identifies two susceptibility loci for duodenal ulcer in the Japanese population. Nat Genet. 2012;44:430-434, S1. doi: 10.1038/ng.1109.
41. Reilly MP, Li M, He J, Ferguson JF, Stylianou IM, Mehta NN, et al; Myocardial Infarction Genetics Consortium; Wellcome Trust Case Control Consortium. Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: two genomewide association studies. Lancet. 2011;377:383-392. doi: 10.1016/S0140-6736(10)61996-4.
42. Williams FM, Carter AM, Hysi PG, Surdulescu G, Hodgkiss D, Soranzo N, et al; EuroCLOT Investigators; Wellcome Trust Case Control Consortium 2; MOnica Risk, Genetics, Archiving and Monograph; MetaStroke; International Stroke Genetics Consortium. Ischemic stroke is associated with the ABO locus: the EuroCLOT study. Ann Neurol. 2013;73:16-31. doi: 10.1002/ana.23838.
43. Hong KW, Moon S, Kim YJ, Kim YK, Kim DJ, Kim CS, et al. Association between the ABO locus and hematological traits in Korean. BMC Genet. 2012;13:78. doi: 10.1186/1471-2156-13-78.
44. Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, Hunter DJ, et al. Finding the missing heritability of complex diseases. Nature. 2009;461:747-753. doi: 10.1038/nature08494.
45. Yang J, Lee SH, Goddard ME, Visscher PM. GCTA: a tool for genomewide complex trait analysis. Am J Hum Genet. 2011;88:76-82. doi: 10.1016/j.ajhg.2010.11.011.
46. Tomiya T, Yamaoka M, Inoue Y, Nishikawa T, Yanase M, Ikeda H, et al. Effect of rapamycin on hepatocyte function and proliferation induced by growth factors. Chemotherapy. 2007;53:59-69. doi: 10.1159/000098420.
47. Tomiya T, Nishikawa T, Inoue Y, Ohtomo N, Ikeda H, Tejima K, et al. Leucine stimulates HGF production by hepatic stellate cells through mTOR pathway. Biochem Biophys Res Commun. 2007;358:176-180. doi: 10.1016/j.bbrc.2007.04.093.
48. Nomura M, Oketa Y, Yasui K, Ishikawa H, Ono S. Expression of hepatocyte growth factor in the skin of amyotrophic lateral sclerosis. Acta Neurol Scand. 2012;125:389-397. doi: 10.1111/j.1600-0404.2011.01579.x.
49. Kadoyama K, Funakoshi H, Ohya W, Nakamura T. Hepatocyte growth factor (HGF) attenuates gliosis and motoneuronal degeneration in the brainstem motor nuclei of a transgenic mouse model of ALS. Neurosci Res. 2007;59:446-456. doi: 10.1016/j.neures.2007.08.017.
50. Sun W, Funakoshi H, Nakamura T. Overexpression of HGF retards disease progression and prolongs life span in a transgenic mouse model of ALS. J Neurosci. 2002;22:6537-6548.